Psilocybin and other psychedelic drugs may still be federally prohibited, Schedule-1 Controlled substances, ostensibly with no accepted medical use. But gold-standard research demonstrating the impressive efficacy and safety of these substances for treating intractable mental health disorders has changed minds even in the FDA. And while far from being a done deal, many expect that the rescheduling of certain psychedelic compounds, and their introduction into routine standard of care, is now just a matter of…

READ MORE: https://www.cannabisculture.com/content/2020/07/18/psychedelics-for-seniors-a-new-sublingual-option/